Utilization Management in Healthcare

Utilization management (UM) is a formal set of clinical review processes that health plans, insurers, and managed care organizations use to evaluate the appropriateness, necessity, and efficiency of healthcare services before, during, or after delivery. The practice operates across inpatient, outpatient, and post-acute care settings and directly shapes whether a proposed treatment, procedure, or level of care receives authorization for coverage. Understanding UM is essential for clinicians, care managers, and patients navigating coverage decisions, because UM determinations affect access to everything from elective surgeries to behavioral health admissions.

Definition and scope

Utilization management is defined by the American Medical Association (AMA) as a set of techniques used by or on behalf of purchasers of health benefits to manage healthcare costs by influencing patient care decision-making through case-by-case assessments of the appropriateness of care prior to its provision (AMA, Principles of Utilization Management).

The regulatory scope of UM spans federal and state levels:

• Federal: The Employee Retirement Income Security Act (ERISA) governs UM practices for self-funded employer health plans. The Centers for Medicare & Medicaid Services (CMS) sets UM standards for Medicare Advantage plans under 42 CFR Part 422, including requirements for prior authorization policies and timely decision-making (CMS, 42 CFR Part 422).
• State: Most states regulate UM for fully-insured commercial plans through insurance department rules, with oversight frameworks that include mandatory review timelines and independent external review rights.
• Accreditation standards: URAC (formerly Utilization Review Accreditation Commission) maintains a dedicated UM accreditation program that establishes staffing, process, and decision-criteria standards for organizations conducting reviews (URAC, Utilization Management Accreditation).

UM intersects directly with risk stratification in care management and value-based care models, as payers increasingly tie authorization criteria to population-level cost and quality data rather than fee-for-service volume.

How it works

UM processes are structured around three temporal phases, each with distinct review types:

1. Prospective review (prior authorization): A clinician or facility submits a request before delivering a service. The UM organization evaluates the request against evidence-based clinical criteria — most commonly InterQual (Change Healthcare) or Milliman Care Guidelines — and issues an approval, denial, or request for additional information. CMS requires Medicare Advantage plans to respond to standard prior authorization requests within 14 calendar days and expedited requests within 72 hours (CMS, Prior Authorization and Step Therapy for Medicare Advantage).

2. Concurrent review: Conducted while a patient is already receiving care — most commonly during an inpatient hospital stay. A UM nurse or physician reviewer evaluates whether continued inpatient status meets medical necessity criteria based on clinical indicators such as severity of illness and intensity of service. This phase links directly to discharge planning and post-acute care decisions, because concurrent review often determines when a transition to a lower level of care is appropriate.

3. Retrospective review: Performed after services have been delivered. Retrospective denials are less common under ERISA-governed plans but remain a tool for identifying billing inconsistencies, upcoding, or care delivered without required authorization.

Within each phase, reviewers apply a structured hierarchy:

• Nurse reviewer: First-line clinical review using approved criteria sets.
• Physician reviewer (same specialty): Required for any denial based on medical necessity; must hold an unrestricted license and, under URAC standards, must practice in a specialty appropriate to the service under review.
• Peer-to-peer consultation: A mechanism allowing the treating clinician to discuss the case directly with the reviewing physician before a final determination is issued.

Common scenarios

UM applies across care settings, but five scenarios account for the majority of review volume in most health plans:

• Inpatient surgical admissions: Prospective review determines whether inpatient vs. outpatient status is appropriate, using criteria that weigh procedural complexity, anesthesia requirements, and anticipated recovery needs.
• Behavioral health inpatient and residential admissions: Among the most scrutinized categories; federal parity requirements under the Mental Health Parity and Addiction Equity Act (MHPAEA) prohibit UM criteria that are more restrictive for behavioral health than for comparable medical/surgical benefits (U.S. DOL, MHPAEA). See also behavioral health care management for related frameworks.
• Post-acute care transitions: Skilled nursing facility (SNF) admissions, home health services, and inpatient rehabilitation require concurrent or prospective authorization confirming that the patient meets Medicare or commercial plan coverage criteria for that level.
• High-cost outpatient procedures: Imaging (MRI, CT, PET), oncology infusions, and specialty drugs frequently require prior authorization. Radiology benefit managers (RBMs) are a subset of UM organizations focused specifically on imaging appropriateness.
• Durable medical equipment (DME): Prospective review verifies that prescribed equipment meets coverage criteria, including documentation of face-to-face clinical encounters and specific diagnostic codes.

Decision boundaries

UM determinations operate within defined boundaries that distinguish them from clinical treatment decisions:

Medical necessity vs. clinical judgment: UM reviewers apply plan-defined criteria to determine whether a service meets the plan's coverage standard — they do not direct clinical treatment. The treating physician retains authority over what care is ordered; the UM organization determines whether that care meets coverage criteria for payment.

Approval vs. denial classification:

External independent review: Under the Affordable Care Act (ACA) Section 2719 and implementing regulations at 45 CFR Part 147, non-grandfathered health plans must offer external review by an Independent Review Organization (IRO) when internal appeals are exhausted (HHS, 45 CFR Part 147). IRO decisions are binding on the plan.

Comparison — prospective vs. retrospective denial: A prospective denial allows the patient to seek alternatives before incurring costs. A retrospective denial places the financial risk on the provider or patient after care is already delivered, making prospective processes the default framework in high-cost service categories.

UM functions as one component within a broader care management regulatory compliance environment and intersects with care management quality metrics when health plans use authorization data to monitor overuse, underuse, and variation in care delivery.

References

• American Medical Association — Principles of Utilization Management
• Centers for Medicare & Medicaid Services — 42 CFR Part 422 (Medicare Advantage)
• CMS — Prior Authorization and Step Therapy for Medicare Advantage
• URAC — Utilization Management Accreditation
• U.S. Department of Labor — Mental Health Parity and Addiction Equity Act (MHPAEA)
• HHS — 45 CFR Part 147 (ACA External Review)
• eCFR — Employee Retirement Income Security Act (ERISA) Overview